FDA Inspection
Lexia LLCLexia LLC – FDA Inspection, Mar 7, 2019
Record Details
This FDA Inspection record concerns Lexia LLC, with an inspection on March 7, 2019, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 7fa9b4c4-a638-40ec-9a0d-63849b40bcf5
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1081647
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
4- 21 CFR 211.137(d)Expiration date location on labeling
- 21 CFR 211.84(d)(2)Reports of Analysis (Components)
- 21 CFR 211.165(a)Testing and release for distribution
- 21 CFR 211.22(c)Approve or reject procedures or specs
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Lexia LLC
1| Date | Classification | Office | Project area |
|---|---|---|---|
| September 29, 2025 | OAI | New Orleans District Office | Drug Quality Assurance |
Other documents for Lexia LLC
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.